Magnetic resonance imaging of focal liver lesions

Applied Radiology

Volumn 30, Issue 4 SUPPL., 2001, Pages 64-74

  Dunphy, T ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADODIAMIDE; GADOLINIUM PENTETATE; GADOTERIDOL; MANGAFODIPIR; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SUPERPARAMAGNETIC IRON OXIDE;

AGE; ARTICLE; BILE DUCT CARCINOMA; CANCER STAGING; CELL TYPE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FOLLOW UP; HEMANGIOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGING SYSTEM; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER CYST; LIVER INJURY; LIVER METASTASIS; LIVER SURGERY; LIVER TUMOR; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PORTAL PHLEBOGRAPHY; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; TISSUE CHARACTERIZATION; TREATMENT PLANNING;

EID: 0035042553     PISSN: 01609963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. CT and MR imaging of hepatic metastases
2. Liver metastases: Comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases
3. MR imaging techniques of the liver
4. Fatty metamorphosis of hepatocellular carcinoma: Detection with chemical shift gradient-echo MR imaging
5. Hepatocellular tumors with high signal on T1-weighted: Chemical shift MR imaging and histologic correlation
6. MR imaging of the liver: Different approaches mandated at high and open fields
7. MR of focal liver lesions: Comparison of breath-hold and non-breath-hold hybrid RARE and conventional spin-echo T2-weighted pulse sequences
8. T2-weighted MR imaging of the abdomen: Fast spin-echo vs. conventional spin-echo sequences
9. MRI in characterization of focal liver lesions: Comparison of T2 weighting by conventional spin-echo and turbo spin-echo sequences J
10. Superparamagnetic iron oxide hepatic MR imaging: Efficacy and safety using conventional and fast spin-echo pulse sequences
11. Metallic artifacts on MR images of the postoperative spine: Reduction with fast spin-echo techniques
12. The emergence of liver-specific MR contrast agents for the detection of focal liver lesions
13. Contrast-enhanced MR Imaging of the liver
14. Hepatobiliary contrast material: A magic bullet for sensitivity and specificity?
15. Current uses of gadolinium chelates for clinical magnetic resonance examination of the liver
16. Biodistribution and toxicity of MR imaging contrast agent media
17. Currently available gadolinium chelates
18. Liver-specific MR imaging contrast agents
19. MR enhancement of hepatoma by super-paramagnetic iron oxide (SPIO) particles
20. Benign hepatocellular tumors: MRI after super-paragmagnetic Iron Oxide Administration
21. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging
22. Assessment of combined superparamagnetic iron oxide and dynamic gadolinium-enhanced MRI for focal liver lesions
23. Detection and characterization of malignant hepatic tumors: Comparison of gadolinium-and ferumoxides-enhanced MR images by using receiver-operating characteristic curve analysis
24. Detection of hepatocellular carcinoma by ferumoxides-enhanced MR imaging in cirrhosis: Incremental value of dynamic gadolinium enhancement
25. Comparison of SPIO-enhanced MRI, gadolinium-enhanced dynamic MRI, combined SPIO- and gadolinium-enhanced MRI, combined CTAP and biphasic CTHA for the detection of hepatocellular carcinoma: ROC analysis
26. Unenhanced, GD-DTPA, and ferumoxides-enhanced MRI in focal hepatic disease: A comparison in over 900 Patients
27. Evaluation and treatment of focal liver mass
28. Comparison of outcome between extended and nonextended liver resections for neoplasms
29. Segmental anatomy of the liver: Utility of a nomenclature accepted worldwide
30. Surgical anatomy and anatomical surgery of the liver
31. Imaging of the liver
32. Benign hepatic tumours and tumourlike conditions in men
33. Hepatic hemangioma in cirrhotics with portal hypertension: Evaluation with Tc-99m red blood cell SPECT
34. Hepatic cavernous hemangiomas: Lack of enlargement over time
35. Nuclear imaging of solid hepatic masses
36. Liver
37. Hepatic hemangiomas
38. Hepatic hemangiomas: A multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images
39. Tumors of the liver and intrahepatic bile ducts
40. On the pathogenesis of focal nodular hyperplasia of the liver
41. Benign liver tumors
42. The prevalence and characterization of simple hepatic cysts by ultrasound examination
43. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use
44. Resolution of a contraceptive steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma
45. The risk of liver neoplasia in relation to combined oral contraceptive use
46. Hepatocellular adenoma: MR imaging features with pathologic correlation
47. Neoplasms of the liver
48. Peripheral washout: A sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions
49. Primary malignant neoplasm in the adult
50. Cirrhosis and premalignant nodules
51. Dysplastic nodules and hepatocellular carcinoma: Thin-section MR imaging of explanted cirrhotic livers with pathologic correlation
52. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma
53. Evaluation of malignant biliary obstruction: Efficacy of fast multiplanar spoiled gradient-recalled MR imaging vs spin-echo MR, CT, and cholangiography
54. Imaging of intrahepatic cholangiocarcinoma: 2. hilar cholangiocarcinoma
55. Liver tumors: Comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA
56. Contrast agents for MR imaging of the liver